July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Fast macular capillary impairment in young patients with uncontrolled type 1 diabetes
Author Affiliations & Notes
  • Carlo Alessandro Lavia
    Service d'ophtalmologie, Hopital Lariboisiere, Paris, San Mauro Torinese, Italy
  • Ali Erginay
    Service d'ophtalmologie, Hopital Lariboisiere, Paris, San Mauro Torinese, Italy
  • Alain Gaudric
    Service d'ophtalmologie, Hopital Lariboisiere, Paris, San Mauro Torinese, Italy
  • Ramin Tadayoni
    Service d'ophtalmologie, Hopital Lariboisiere, Paris, San Mauro Torinese, Italy
  • Benedicte Dupas
    Service d'ophtalmologie, Hopital Lariboisiere, Paris, San Mauro Torinese, Italy
  • Footnotes
    Commercial Relationships   Carlo Alessandro Lavia, None; Ali Erginay, ALLERGAN INC (R), BAYER HEALTHCARE (R), NOVARTIS PHARMACEUTICALS CORPORATION (R); Alain Gaudric, BAYER HEALTHCARE (R), NOVARTIS PHARMACEUTICALS CORPORATION (R), THROMBOGENICS (R); Ramin Tadayoni, ALCON (R), ALLERGAN INC (R), BAYER HEALTHCARE (R), NOVARTIS PHARMACEUTICALS CORPORATION (R), ZEISS (S); Benedicte Dupas, BAYER HEALTHCARE (R), NOVARTIS PHARMACEUTICALS CORPORATION (R)
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 5318. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Carlo Alessandro Lavia, Ali Erginay, Alain Gaudric, Ramin Tadayoni, Benedicte Dupas; Fast macular capillary impairment in young patients with uncontrolled type 1 diabetes. Invest. Ophthalmol. Vis. Sci. 2019;60(9):5318.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To analyze the evolution of macular vessel density (VD) within three vascular plexuses using optical coherence tomography angiography (OCTA) over 1 year in patients with uncontrolled type 1 diabetes (T1D).

Methods : Retrospective study of 12 eyes of 8 T1D patients with early worsening diabetic retinopathy imaged with OCT-Angiography (RTVue XR Avanti; Optovue, Fremont, CA, USA) with phase 7 AngioVue software implemented with the Projection Artifacts Removal (3D-PAR). 3x3 mm scans centered on the fovea were analysed and follow-up examination mode was employed.
Inclusion criteria were: T1D, age <40 years, presence of bilateral and rapidly progressive (over a 6-month period) DR requiring prompt and dense panretinal photocoagulation (PRP), abscence of past or present diabetic ME (DME), good OCT-A image quality.
Data were collected at the time of panretinal photocoagulation initiation and after 6 and 12 months, including VD within 3 retinal plexuses - superficial (SVP), intermediate (ICP) and deep (DCP); foveal avascular zone (FAZ) area, acircularity index (AI) and flow density (FD)-300; central macular thickness (CMT); HbA1c levels.

Results : Patient mean age was 28.9 ± 5.4 years, 5 were males. A history of rapid reduction in blood glucose was found in 7 out of 8 cases. VD was significantly decreased in all vascular plexuses at 6 and 12 months: in the SVP it falled from 43.55±4.31 to 39.87±7.34 (p=0.008), in the ICP from 41.95±4.13 to 36.82±7.89 (p=0.03), and in the DCP from 21.94±4.08 to 19.06±4.62 (p=0.004). ICP and DCP VD changes were significantly correlated (r=0.81, p<0.001). The mean FAZ area increased from 0.41 ± 0.23 mm2 to 0.45 ± 0.28 mm2 (p=0.07) and 0.49 ± 0.30 mm2 (p=0.05) at 6 and 12 months (p=0.04) and the FD-300 decreased (p=0.03) over time. No significant change in AI, CMT and visual acuity were observed over time.

Conclusions : Young T1D patients with uncontrolled diabetes and fast progression of DR treated with PRP showed a rapid decrease in macular VD and an increase in FAZ area at 6 months and continuing over 1 year. The capillary loss was faster in the deep capillary plexuses (ICP and DCP) than in the SVP. Despite these findings, VA didn't significantly decrease over time.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×